Summary
Eleven studies (10 randomised controlled trials and 1 large open study) that evaluated quality of life (QOL) are reviewed. The areas of QOL measured by the studies are compared and a consensus is reported that health-related QOL measures in patients with hypertension should include: symptomatic and psychological well-being, activity (work, leisure, sleep, sexual activity and social participation), cognitive function and life satisfaction. Recommended methods for measuring these aspects of QOL are noted.
Seven studies included atenolol as 1 of the treatments and the effects of this drug on QOL are reviewed. The drug appears to maintain QOL as well as the angiotensin converting enzyme (ACE) inhibitors captopril, enalapril and cilazapril. One trial also suggests that verapamil maintains QOL as well as atenolol, although this was not suggested by the nonrandomised study. Nifedipine slow release (SR) and propranolol both fared worse than atenolol in 2 separate trials, but 1 trial suggested that nifedipine gastrointestinal therapeutic system (GITS) was preferred to atenolol in terms of QOL. In the latter study, however, only patients completing the prescribed therapy revealed a preference for nifedipine GITS; this was absent in an intention-to-treat analysis. The rate of discontinuation of nifedipine therapy was high, underlining the necessity for an intention-to-treat analysis in trials assessing QOL.
Similar content being viewed by others
References
Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Medical Care 19: 787–805, 1981
Bulpitt CJ, Fletcher AE. The measurement of quality of life in hypertensive patients: a practical approach. British Journal of Clinical Pharmacology 30: 353–364, 1990
Campbell A, Converse PE, Rodgers WL. The quality of American life, p. 554, Russell Sage Foundation, New York, 1976
Croog SJ, Kong BW, Levine S, Weir MR, Baume RM, et al. Hypertensive black men and women: quality of life and effects of antihypertensive medications. Archives of Internal Medicine 150: 1733–1741, 1990
Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, et al. The effects of antihypertensive therapy on the quality of life. New England Journal of Medicine 314: 1657–1664, 1986
Derogatis LR, Lipman RS, Covi L. The SCL-90: an outpatient psychiatric rating scale. Psychopharmacology Bulletin 9: 13–28, 1973
Derogatis LR, Spencer PM. The brief symptom inventory (BSI), administration, scoring and procedures manual I. Johns Hopkins University School of Medicine, Baltimore, privately printed, 1982
Dupuy HJ. The psychological general well-being (PGWB) index. In Wenger et al. (Eds) Assessment of quality of life in clinical trials of cardiovascular therapies, pp. 170–183, LeJacq, New York, 1984
Fletcher AE, Bulpitt CJ. Quality of life during antihypertensive treatment: results from a randomised double-blind trial of pinacidil and nifedipine. Journal of Hypertension 7 (Suppl. 6): S364, 1989
Fletcher AE, Bulpitt CJ, Chase DM, Collins WCJ, Furberg CD, et al. Quality of life on three antihypertensive treatments: cilazapril, atenolol, nifedipine. Second International Symposium on ACE Inhibition, London, 17–21 February 1991.
Fletcher AE, Bulpitt CJ, Hawkins CM, Havinga TK, ten Berge BSt, et al. Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol. Journal of Hypertension 8: 463–466, 1990
Fletcher AE, Chester PC, Hawkins CMA, Latham SN, Pike LA, et al. The effects of verapamil and propranolol on quality of life in hypertension. Journal of Human Hypertension 3: 125–130, 1989
Fletcher AE, Hunt BM, Bulpitt CJ. Evaluation of quality of life in clinical trials in cardiovascular disease. Journal of Chronic Disease 40: 557–566, 1987
Goldberg D. Manual of the general health questionnaire, Windsor NFER-Nelson Publishing Company, 1978
Harrison WM, Stewart J, Ehrhardt AA, Rabkin J, McGrath P, et al. A controlled study of the effects of antidepressants on sexual function. Psychopharmacology Bulletin 21: 85–88, 1985
Hatchett S, Schuman H. White respondents and race of interviewer effects. Public Opinion Quarterly 34: 523–528, 1975
Herrick AL, Waller PC, Bernn KE, Pringle SD, Callender JS, et al. Comparison of enalapril and atenolol in middle to moderate hypertension. American Journal of Medicine 86: 421–426, 1989
House JS. Work stress and social support, Addison Wesley, Reading, 1981
Kellner R, Sheffield BF. A self-rating scale of distress. Psychological Medicine 3: 88–100, 1973
Ley P. The measurement of comprehensibility. Journal of the Institute of Health Education 11: 17–20, 1973
McNair DM, Lorr M, Doppleman LF. Manual for the profile of mood states. San Diego Educational and Industrial Testing Services, 1971
Palmer A, Fletcher A, Hamilton G, Muriss S, Bulpitt C. A comparison of verapamil and nifedipine on quality of life. British Journal of Clinical Pharmacology 30: 365–370, 1990
Reitan RM. Trail making manual for administration, scoring, and interpretation. Department of Neurology, Section of Neuropsychology, Indiana University Medical Center, Indianapolis, 1958
Rey A. L’examine psychologique dans les cas d’encephalopathie traumatique. Archiv für Psychologie 28: 286–340, 1941
Spielman AJ, Tannebaum R, Saskin P, et al. A comparison between objective and subjective sleep latency in patients with chronic insomnia. Abstract. Sleep Research 9: 225, 1980
Steiner SS, Friedhoff AJ, Wilson BL, Wecker JR, Santo JP. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol. Journal of Human Hypertension 4: 217–225, 1990
Stelmach WJ, Rush DR, Brucker PC, Holverson H, Emmett ID, et al. A report from CEN. Managing hypertension in family practice: a nationwide collaborative study of the use of four antihypertensives in the treatment of mild-to-moderate hypertension. Journal of the American Board of Family Practice 2: 172–190, 1989
Testa MA, Hollenberg NK, Anderson RB, Williams GH. Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system. American Journal of Hypertension 4: 363–373, 1991
Testa MA, Simonson DC. Measuring quality of life in hypertensive patients with diabetes. Postgraduate Medical Journal 64 (Suppl. 3): 50–58, 1988
Veit CT, Ware JE. The structure of psychological distress and well-being in general populations. Journal of Consulting and Clinical Psychology 51: 730–742, 1983
Wechsler D. A standardized memory scale for clinical use. Journal of Psychology 19: 87–95, 1945
Wechsler D. Manual for the Wechsler adults intelligence scale. Psychological Corporation, New York, 1985
Weissman MM, Bothwell S. Assessment of social adjustment by patient self report. Archives of General Psychiatry 33: 1111–1115, 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bulpitt, C.J., Fletcher, A.E. Quality of Life Evaluation of Antihypertensive Drugs. Pharmacoeconomics 1, 95–102 (1992). https://doi.org/10.2165/00019053-199201020-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199201020-00006